Adenine

Adenine

SCHEMBL28763032

Nc1ncnc2nc[nH]c12.O=C(O)Cl

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 2/20 0.76
▸ PI4K2B Q8TCG2 2/20 0.76
▸ PI4K2A Q9BTU6 2/20 0.76
▸ PI4KB Q9UBF8 2/20 0.76
▸ LMNA P02545 2/20 0.76
▸ LRRK2 Q5S007 2/20 0.76
▸ DRD3 P35462 1/20 0.76
▸ XDH P47989 1/20 0.76
▸ BRD4 O60885 1/20 0.46
▸ PDPK1 O15530 3/20 0.44
▸ TOP2A P11388 2/20 0.44
▸ GDA Q9Y2T3 1/20 0.44
▸ G6PD P11413 1/20 0.44
▸ BRAF P15056 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MKNK1 Q9BUB5 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenine SCHEMBL385842 0.91 LMNA (0.92) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL31591098 0.90 PI4KA (0.76) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL14125908 0.90 PI4KA (0.76) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL9621210 0.89 PI4KA (0.81) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL1331751 0.87 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL29355156 0.87 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL29442902 0.87 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL3414606 0.87 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL8111 0.87 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBLMNA
Adenine SCHEMBL29982697 0.87 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1845745-B Use of TLR7 ligand and prodrug thereof in preparation of drugs for treating hepatitis c virus infection ANADYS PHARMACEUTICALS INC 2011-11-02 — — CN disclosed
CN-1845745-A Administration of TLR7 ligands and prodrugs thereof for the treatment of hepatitis C virus infection ANADYS PHARMACEUTICALS INC (US) 2006-10-11 — — CN disclosed
Send feedback